Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
FCM, Neutralization, SPR
Human
IgG1
4V2
SARS-CoV-2
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
VIR-7229
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
3A1
SARS-CoV-2 (2019-nCoV), Mers-CoV
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
CC99.103
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
SARS-CoV-2(2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
XG005M
SARS-CoV-2
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
BD55-5840
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
VHH-hFc (IgG1)
3-2A2-4
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
H014
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
COVA1-16